GENERIC NAME OF THE MEDICINAL PRODUCT:
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Release Tablet contains:
Epalrestat………………....…………………..150mg
Excipients…………………………………..………q.s.
Colours: Sunset Yellow.
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
SCHEDULE: SCHEDULE H: It is not recommended for children as its safety and effectiveness have not been established in this group.
STORAGE & DOSAGE:
Dosage: As directed by the Physician
Epalrestat Sustained Release Tablets 150mg Technical Specification:
| Product Name: | Epalrestat Sustained Release Tablets 150mg |
| Brand Name: | Epataj – SR |
| Strength: | 150mg |
| Dosage Form: | Film-Coated Tablet |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Diabetic Peripheral Neuropathy |
| Indication: | Epalrestat is indicated for the improvement of subjective symptoms (numbness and pain), abnormality of vibration sense and abnormal change in heartbeat associated with diabetic peripheral neuropathy (when high glycohemoglobin value is noted). |
| Storage: | Store in a cool, dry & dark place. protect from light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Epalrestat Sustained Release Tablets 150mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Each film coated Sustained:
Release Tablet contains:
Epalrestat………………….…………………..150mg
Excipients…………………………………..………q.s.
Colours: Sunset Yellow.
THERAPEUTIC INDICATIONS:
Treats nerve damage, providing relief from symptoms such as pain, tingling, numbness, and burning sensations.Enhances nerve conduction velocity and reduces nerve damage progression.
CAUTION & SCHEDULE:
CAUTION: Not to be sold by retail without the prescription of a Registered medical practitioner.
SCHEDULE: SCHEDULE H: It is not recommended for children as its safety and effectiveness have not been established in this group.
STORAGE & DOSAGE:
Storage: Store in a cool, dry & dark place. Protect from light . keep the medicine out of reach of children do not chew or crush the tablets.
Dosage: As directed by the Physician.
Introduction to Epalrestat Sustained Release Tablets 150mg
Epalrestat Sustained Release Tablets 150mg are widely prescribed pharmaceutical tablets primarily used for the treatment of Diabetic Peripheral Neuropathy (DPN), a common complication in patients suffering from long-term diabetes. This medication belongs to a class of drugs known as aldose reductase inhibitors, which help prevent nerve damage caused by high blood sugar levels.
As diabetes prevalence continues to rise worldwide, the demand for effective treatments addressing diabetic complications has increased significantly. Epalrestat Sustained Release Tablets 150mg play a crucial role in managing nerve damage by reducing the accumulation of sorbitol in nerve cells, which is responsible for diabetic nerve disorders.
Taj Pharma, the well-known Epalrestat Sustained Release Tablets 150mg manufacturer in India, ensures high levels of quality, purity, and efficacy. The formulation helps relieve symptoms such as pain, tingling, numbness, and burning sensations in the hands and feet, while also contributing to long-term nerve protection and improved nerve function.
Manufactured at advanced pharmaceutical facilities in Vapi, Gujarat, India, Taj Pharma supplies Epalrestat Sustained Release Tablets 150mg PAN India and exports them globally, making the company a trusted partner for pharmaceutical distributors, wholesalers, hospitals, and international importers.
Understanding the Role of Epalrestat in Diabetic Neuropathy
Epalrestat functions as a powerful aldose reductase inhibitor that blocks the enzyme responsible for converting glucose into sorbitol inside cells. In diabetic patients, excess sorbitol accumulates within nerve tissues, causing nerve damage and neuropathy.
By inhibiting this process, Epalrestat Sustained Release Tablets 150mg help:
-
Prevent sorbitol buildup in nerve cells
-
Improve nerve blood circulation
-
Reduce oxidative stress on nerves
-
Relieve neuropathic symptoms
-
Support long-term nerve function
This makes the medicine extremely beneficial for patients experiencing diabetic nerve pain, burning sensations, numbness, and tingling in extremities.
Medical Uses of Epalrestat Sustained Release Tablets 150mg
Doctors prescribe Epalrestat Sustained Release Tablets 150mg for several diabetic nerve complications.
Primary Indications
-
Diabetic Peripheral Neuropathy (DPN)
-
Nerve pain associated with diabetes
-
Burning sensations in hands and feet
-
Numbness and tingling due to nerve damage
-
Long-term diabetic nerve protection
Patients suffering from diabetic neuropathy can experience significant improvement in symptoms with consistent therapy.
Advice for Patients with Diabetic Neuropathy
Managing diabetic neuropathy requires both medication and lifestyle management.
Patients should:
-
Follow regular antidiabetic therapy
-
Maintain stable blood glucose levels
-
Wear protective footwear
-
Examine feet daily for wounds or lesions
-
Avoid weight-bearing activities if a foot injury or open wound is present
Proper care and treatment with medicines such as Epalrestat Sustained Release Tablets 150mg can help delay or prevent progression of diabetic nerve disease.
Epalrestat Sustained Release Tablets 150mg Manufacturer in India
Taj Pharma Ltd India is a well-recognized manufacturer, exporter, and supplier of Epalrestat Sustained Release Tablets 150mg from Vapi, Gujarat, India. With decades of pharmaceutical manufacturing expertise, the company has developed a strong reputation for delivering high-quality medicines at competitive global prices.
Our pharmaceutical production facilities follow strict WHO-GMP manufacturing guidelines, ensuring that every batch of tablets meets international quality standards.
Manufacturing Highlights
-
WHO-GMP certified production units
-
Advanced pharmaceutical machinery
-
Automated tablet compression technology
-
Strict quality control laboratories
-
Skilled pharmaceutical scientists
Through continuous innovation and quality monitoring, Taj Pharma delivers consistent pharmaceutical excellence.
In-Depth Details for Importers, Exporters & Global Buyers
Taj Pharma offers complete export support for Epalrestat Sustained Release Tablets 150mg export from India, making international procurement easy for pharmaceutical distributors.
Regulatory Documentation Provided
We provide comprehensive documentation required for pharmaceutical import and regulatory approvals:
-
Certificate of Pharmaceutical Product (COPP)
-
WHO-GMP Certification
-
EU-GMP Compliance (if required)
-
CTD / ACTD Dossier
-
Product Specification Sheets
-
Certificate of Analysis (COA)
-
Stability Data Reports
-
MSDS Documentation
These documents ensure smooth product registration and regulatory approvals in international markets.
Custom Packaging & Labeling
Taj Pharma provides flexible packaging solutions tailored for global buyers.
Options include:
-
Blister packaging
-
Alu-Alu packaging
-
HDPE bottles
-
Bulk export packaging
-
Private labeling / contract manufacturing
This allows distributors to market Epalrestat Sustained Release Tablets 150mg under their own brand names.
Shelf Life, Storage & Dosage Form
-
Dosage Form: Sustained Release Tablets
-
Strength: 150mg
-
Shelf Life: 24–36 months
-
Storage Conditions: Store in a cool, dry place away from moisture and direct sunlight
-
Packaging: Blister packs / bottles
Export Certifications & Compliance
Taj Pharma ensures that every exported pharmaceutical product complies with international regulatory standards.
Key Export Certifications
-
WHO-GMP Certification
-
ISO Certified Manufacturing
-
COPP Certification
-
CTD Dossier Availability
-
Product Registration Support
These certifications make Taj Pharma a reliable global pharmaceutical supplier.
Global Export Markets for Epalrestat Tablets
Taj Pharma exports pharmaceutical formulations to more than 40 countries worldwide.
Top 20 Countries We Export To
Nigeria || Kenya || Ghana || Uganda || South Africa || UAE || Saudi Arabia || Oman || Qatar|| Kuwait || Russia || Kazakhstan || Uzbekistan || Kyrgyzstan || Vietnam || Philippines || Myanmar || Sri Lanka || Peru || Chile ||
Why Taj Pharma is the Most Trusted Manufacturer & Exporter
1. State-of-the-Art Pharmaceutical Manufacturing
Taj Pharma operates advanced manufacturing facilities equipped with modern machinery and strict quality systems that ensure safe and effective pharmaceutical production.
2. Affordable Pricing with Premium Quality
Our large-scale production allows us to offer competitive global pricing without compromising quality.
3. Strong Global Supply Chain
With experienced export teams and logistics partners, Taj Pharma ensures timely delivery to international buyers.
4. Trusted Pharmaceutical Brand
Decades of pharmaceutical expertise have made Taj Pharma a trusted global exporter of high-quality medicines.
Technical Product Specification
| Parameter | Details |
|---|---|
| Product Name | Epalrestat Sustained Release Tablets |
| Strength | 150 mg |
| Dosage Form | Sustained Release Tablet |
| Therapeutic Category | Anti-diabetic Neuropathy Medicine |
| Active Ingredient | Epalrestat |
| Shelf Life | 24–36 Months |
| Packaging | Blister / Bottle |
| Manufacturing Location | Vapi, Gujarat, India |
| Certifications | WHO-GMP, COPP |
| Export Availability | Worldwide |
Possible Side Effects
Like most medicines, Epalrestat Sustained Release Tablets 150mg may cause mild side effects in some patients.
Common Side Effects
-
Nausea
-
Vomiting
-
Abnormal liver function
Most side effects do not require medical attention and usually disappear as the body adjusts to the medicine. Patients should consult their doctor if symptoms persist.
Top 20 Frequently Asked Questions
1. What is Epalrestat Sustained Release Tablets 150mg used for?
It is used to treat diabetic peripheral neuropathy and reduce nerve damage caused by diabetes.
2. How does Epalrestat work?
It blocks the enzyme aldose reductase, preventing sorbitol accumulation in nerve cells.
3. Who manufactures Epalrestat Sustained Release Tablets 150mg in India?
Taj Pharma is a leading Epalrestat Sustained Release Tablets 150mg Manufacturer in India.
4. Where are these tablets manufactured?
They are manufactured in Vapi, Gujarat, India.
5. Can Taj Pharma export Epalrestat tablets globally?
Yes, Taj Pharma exports pharmaceutical medicines worldwide.
6. What certifications does Taj Pharma provide?
WHO-GMP, COPP, CTD Dossier, and regulatory documentation.
7. What is the shelf life of Epalrestat tablets?
The typical shelf life is 24–36 months.
8. What packaging options are available?
Blister packs, bottles, and custom export packaging.
9. Does Taj Pharma offer private labeling?
Yes, private label and contract manufacturing services are available.
10. What conditions does Epalrestat treat?
It treats diabetic nerve damage and neuropathy symptoms.
11. Is Epalrestat safe for long-term use?
It should be used as directed by a doctor.
12. Can Epalrestat improve nerve function?
Yes, it helps support long-term nerve health.
13. Are there any side effects?
Possible side effects include nausea and vomiting.
14. Can exporters obtain regulatory dossiers?
Yes, Taj Pharma provides complete regulatory documentation.
15. Does Taj Pharma support international product registration?
Yes, registration support is available.
16. Is Taj Pharma a WHO-GMP manufacturer?
Yes, Taj Pharma follows WHO-GMP manufacturing standards.
17. What is the dosage form?
Sustained Release Tablets.
18. Can distributors partner with Taj Pharma?
Yes, through PCD Pharma Franchise opportunities.
19. Does Taj Pharma supply PAN India?
Yes, the company supplies medicines across India.
20. How can buyers contact Taj Pharma?
Buyers can contact via phone, email, or WhatsApp for product inquiries.
Contact Taj Pharma
Taj Pharma Ltd – India
Tel. No.: +91 – 22 – 2637 4592 (IST)
+91 – 22 – 2637 4593
Mobile / WhatsApp:
+91 74 0000 9975
+91 74 0000 9976






